Status:

COMPLETED

Effect of the 1-hour Sepsis Bundle on In-hospital Mortality in Patients With Sepsis in the Emergency Department

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Conditions:

Sepsis

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Reducing the mortality and morbidity of sepsis is a worldwide priority for almost 20 years. Since an observational study in the NY state, which reported in-hospital mortality increased, associated wit...

Detailed Description

In Europe, one third of patients with sepsis and septic shock are admitted through the emergency department (ED), with an overall in-hospital mortality of 20%, and 90 days mortality of 25%. Reducing t...

Eligibility Criteria

Inclusion

  • ED adult patients, with suspected infection
  • Free given Oral consent given by the patient or by the trustworthy person / family member / close relative or inclusion in case of emergency.
  • AND at least one of the following:
  • Serum lactate \> 2.0 mmol/l
  • Systolic blood pressure \< 90 mmHg
  • Suspicion of sepsis as defined by the SEPSIS-3 International consensus: life threatening organ dysfunction identified by a SOFA score of 2 at least or a quick SOFA score of 2 at least (altered consciousness, systolic blood pressure \< 100 mmHg, respiratory rate \> 22)
  • For French sites, free given Oral consent given by the patient or by the trustworthy person / family member / close relative or inclusion in case of emergency. According to the Biomedical Research Law 14/2007 in Spain, the emergency consent is not apply. The written patient consent is mandatory.

Exclusion

  • Patient living in assisted-living home or nursing home or palliative center
  • Patient under legal protection measure (tutorship or curatorship) and patient deprived of freedom
  • Anticipated life expectancy \< 3 months or "do not resuscitate" order
  • Known acute heart failure
  • No social security
  • Pregnancy and breastfeeding
  • Prisoners
  • Participation in another interventional trial (RIPH 1 et 2)
  • Patients that presented inclusion criteria more than 3 hours before inclusion
  • Patient in whom antibiotics or fluid resuscitation has been started before inclusion

Key Trial Info

Start Date :

June 13 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 13 2023

Estimated Enrollment :

873 Patients enrolled

Trial Details

Trial ID

NCT05273034

Start Date

June 13 2022

End Date

October 13 2023

Last Update

February 26 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Emergency department Hospital Pitié-Salpêtrière

Paris, France, 75013